Patient-generated evidence to improve outcomes, support decision making, and accelerate innovation
HORIZON JU Research and Innovation Actions
Basic Information
- Identifier
- HORIZON-JU-IHI-2022-03-02
- Programme
- HORIZON-JU-IHI-2022-03-single-stage
- Programme Period
- 2021 - 2027
- Status
- Closed (31094503)
- Opening Date
- December 13, 2022
- Deadline
- March 15, 2023
- Deadline Model
- single-stage
- Budget
- €138,000,000
- Min Grant Amount
- €10,000,000
- Max Grant Amount
- €14,000,000
- Expected Number of Grants
- 2
- Keywords
- HORIZON-JU-IHI-2022-03-02HORIZON-JU-IHI-2022-03-single-stageChronic diseasesElectronic patient filesHealth dataHealth outcomesPersonalised medicine
Description
The following impacts are expected:
- Enable the added value of people-centred integrated healthcare solutions1 to be assessed according to criteria that matter to patients and citizens, using patient-reported outcome measures (PROMs), patient preference information (PPI), and patient-reported experience measures (PREMs).
- Facilitate the development and implementation of integrated healthcare solutions based on patient input including PROMs, PPI, and PREMs. These solutions should better respond to the needs and preferences of patients and citizens and support an inclusive approach.
- Enable the smart use of patient input and patient-generated evidence to facilitate the faster market entry of patient-centric and cost-effective advanced integrated healthcare solutions1, and also spur further innovation by improving return on research and innovation investments.
- Use patient input gathered via m-health, e-health and other technologies to gain improved insights into the real-life behaviour of, and challenges faced by, patients of all ages with complex, chronic diseases and co-morbidities.
1 Integrated healthcare solutions are innovative solutions integrating various technologies, coupled with complementary tools and services.
Expected Outcome:Research and innovation (R&I) actions (projects) to be supported under this topic should aim to deliver results that contribute to all of the following expected outcomes for the use cases selected:
- Decision makers have new methods for the integration of PROMs, PPI, and PREMs and other people-generated information into regulatory and health technology assessment (HTA) evaluation processes for integrated healthcare solutions.
- Patients of all ages have access to novel integrated healthcare solutions1 that are developed using structured patient input and better respond to their needs and preferences.
- Researchers have new methodological approaches to elicit and integrate patient preferences into the conception, development, and implementation of integrated healthcare solutions1.
- Researchers have wider access to interoperable, quality patient input and patient-generated data, respecting the FAIR (findable, accessible, interoperable, reusable) principles, facilitating the research and development of integrated healthcare solutions.
- Researchers are provided with new outcomes, outcome measures and the time horizon over which value should be assessed to develop appropriate tools and methods for the collection and analysis of PROMs, PPI, and PREMs.
1 Integrated healthcare solutions are innovative solutions integrating various technologies, coupled with complementary tools and services.
Scope:The amount of health data generated by citizens themselves is rapidly increasing. Such data includes patient-reported outcome measures (PROMs), patient preference information (PPI), and patient-reported experience measures (PREMs), as well as other digital health data/digital biomarkers. While the potential for these data to be harnessed to improve individual healthcare is enormous, these data are often fragmented among multiple providers, so that neither the citizen, nor the healthcare ecosystem have a comprehensive overview, and therefore it is very challenging to fully use these data to provide reliable evidence for decision-makers, and to improve health outcomes.
Research and innovation (R&I) actions to be supported under this topic will aim to address this challenge by:
- Developing a framework to integrate patient input and patient-generated data for use in decision making (regulatory, health economic evaluation, reimbursement, healthcare programme design, tailored prescription of therapies, and technology development), benefit-risk evaluation and value assessment of integrated healthcare solutions.1 Applicants should build on existing frameworks where appropriate and appropriately address ethics considerations.
- Implement several use cases to support and demonstrate the use of the framework, focusing on using patient input and patient-generated evidence to address challenges that are not adequately addressed by other initiatives. These use cases should demonstrate the value of using patient input (PROMs, PPI, PREMs) and patient generated data (digital health data/digital biomarkers) along the healthcare continuum, including showcasing improvements to data interoperability, healthcare workflows and processes, disease prevention, and care, including home-based care. These use cases should also act as examples of best practice for future use of the framework.
- Facilitating multi-stakeholder access to patient inputs and patient-generated health data such that actionable harmonised data can be used for quality decision making.
- Comparing/contrasting the properties of the three types of patient input (PROMs, PPI, PREMs), identify differences and opportunities for integrated/complementary use.
- Developing an approach or approaches to integrating PROMs, PPI, and PREMs data into the design of core outcomes sets, end-to-end patient treatment pathways, clinical decision support systems, and treatment guidelines. The core outcome sets used within the project should be made available more widely where possible.
Applicants are expected to seek engagement with regulators where relevant (e.g. through the EMA Innovation Task Force, scientific advice) and consider allocating appropriate resources to explore synergies with other relevant initiatives and projects.
Eligibility & Conditions
General conditions
Please read carefully all provisions stated below before preparing the application.
Please note that the IHI JU 3rd Call for proposals full topic text is available here
General conditions
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Horizon Europe Work Programme General Annexes and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the IHI JU Work Programme (WP)
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes
-
Award criteria, scoring and thresholds are described in Annex D of the Horizon Europe Work Programme General Annexes and in the''Conditions of the Calls for proposals and Calls management rules'' section of the IHI JU Work Programme (WP)
-
Submission and evaluation processes are described in Annex F of the Work Programme General Annexes and the Online Manual
-
Indicative timeline for evaluation and grant agreement: described in Annex F of the Work Programme General Annexes
6. Legal and financial set-up of the grants: described in Annex G of the Work Programme General Annexes
Specific conditions
7. Specific conditions: described in the ''Conditions of the Calls for proposals and Calls management rules'' section of the IHI JU Work Programme (WP)
- specific conditions on Availability, Accessibility and Affordability (3A) do not apply to this topic
- JU's right to object to transfer/exclusive licensing
Documents
Call documents:
Evaluation form (single and two-stage calls)
- IHI JU Evaluation form for Research and Innovation Actions (single and two-stage Calls)
Proposal Templates Part A and Part B (Research and Innovation Actions – single-stage and second stage of two-stage procedure)
- Proposal template - Part A of the proposal is generated by the IT system in the submission environment (for more information see the HE Part A template here). In Part A of the proposal applicants insert general information on their proposal (e.g. proposal acronym), details on the participants, on the budget, information on Ethics and Security, as well as other type of questions (e.g. information on clinical studies). Please note that only Part A of this template is applicable for this call. For Part B, see point below.
- IHI JU Proposal template (RIA/FP) - Part B
Proposal Annexes
- Annex: Type of Participants
The “type of participants” is an IHI specific annex. The excel template can be found here and the instructions on how to fill in this template can be found here.
This is a compulsory annex and it must be uploaded as a separate document in the submission system.
This annex is applicable to single-stage and two-stage Calls.
- Annex: Declaration of in-kind contribution commitment
The “Declaration of in-kind contribution commitment” is an IHI specific annex.
The word document template can be found here.
This is a is a compulsory annex and it must be uploaded as a separate document in the submission system.
This annex is applicable to all single-stage Calls.
- Annex: In-kind contributions to additional activities (IKAA)
The ‘’In-kind contributions to additional activities (IKAA)’’ is an IHI specific annex. The excel template can be found here and the instructions on how to fill in this template can be found here.
This is an optional annex and it is applicable to all single-stages Calls and the second stage of two-stage Calls.
- Annex: Essential information for clinical studies
The information on clinical studies is a Horizon Europe annex.
This is a is a compulsory annex and it must be uploaded as a separate document in the submission system.
The information on clinical studies annex can be found here
The annex is applicable only for single-stage Calls and the second stage of two-stage Calls.
- Annex: Ethics
This is a HE annex. Ethics self-assessment should be included in proposal part A. However, in Calls where several serious ethics issues are expected, the characters limit in this section of proposal part A may not be sufficient for participants to give all necessary information. In those cases, participants may include additional information in an annex to proposal part B.
This is an optional annex and it is applicable to all single-stage Calls and the second stage of two-stage Calls.
Model Grant Agreement (MGA)
Additional documents:
IHI Specific documents
- Council Regulation (EU) 2021/2085 of 19 November 2021 establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014 (in short Single Basic Act ‘SBA’ or Council Regulation (EU) 2021/2085).
- Strategic Research and Innovation Agenda (SRIA)
- IHI JU Guidelines for in-kind contributions to additional activities (IKAA)
- Budget tool - This tool allows to check that the budget table is completed correctly, and that the proposal's budget meets the 45% eligibility threshold. Note that this tool is merely designed to help prepare a proposal. The resulting document should not be submitted to IHI as part of the proposal
Horizon Europe Reference documents
- HE Main Work Programme 2021–2022 – 1. General Introduction
- HE Main Work Programme 2021–2022 – 4. Health
- HE Main Work Programme 2021–2022 – 12. Missions
- HE Main Work Programme 2021–2022 – 13. General Annexes
- HE Framework Programme and Rules for Participation Regulation 2021/695
- HE Specific Programme Decision 2021/764
- Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment
- EU Grants AGA — Annotated Model Grant Agreement
- Funding & Tenders Portal Online Manual
Support & Resources
All the information concerning the IHI JU Calls is also published on the IHI JU website.
All the questions pertaining to the IHI JU Calls are to be addressed to [email protected].
IT-related questions (i.e. forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.) concerning the submission tool/portal need to be addressed directly to the IT Helpdesk in charge with the Funding and Tenders Portal.
Online Manualis your guide on the procedures from proposal submission to managing your grant.
Horizon Europe Programme Guide contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.
Funding & Tenders Portal FAQ – find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.
Research Enquiry Service – ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.
National Contact Points (NCPs) – get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (‘third-countries’).
Enterprise Europe Network – contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.
European IPR Helpdesk assists you on intellectual property issues.
CEN-CENELEC Research Helpdesk and ETSI Research Helpdesk – the European Standards Organisations advise you how to tackle standardisation in your project proposal.
The European Charter for Researchers and the Code of Conduct for their recruitment– consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.
Partner Search Services help you find a partner organisation for your proposal.
Latest Updates
An overview of the evaluation results of IHI Call 3 can be found in the Flash Call Info Report.
Call HORIZON-JU-IHI-2022-03-single-stage has closed as of the 15th of March 2023.
19 proposals have been submitted in total. The breakdown per topic is:
HORIZON-JU-IHI-2022-03-01: 10 proposals
HORIZON-JU-IHI-2022-03-02: 4 proposals
HORIZON-JU-IHI-2022-03-03: 2 proposals
HORIZON-JU-IHI-2022-03-04: 1 proposal
HORIZON-JU-IHI-2022-03-05: 2 proposals
Evaluation results are expected to be communicated in June 2023.